Clinical Trial Update: Multi-center Clinical Study on Hemoperfusion of KHA80 [NA]

View source ↗

Summary

A multi-center clinical study evaluating hemoperfusion using KHA80 for uremia and related conditions is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremia
• Uremic Osteodystrophy

Drugs mentioned

• KHA80 Hemoperfusion

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Uremia, Uremic Osteodystrophy | NA | Status: RECRUITING